Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Ordinary Shares, nominal value 0.05 GBP per share
-
Shares outstanding
-
84,213,667
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
64,968,404
-
Shares change
-
+2,440,984
-
Total reported value, excl. options
-
$1,066,709,124
-
Value change
-
+$34,858,183
-
Put/Call ratio
-
307%
-
Number of buys
-
44
-
Number of sells
-
44
-
Price
-
$16.30
Institutional Holders of Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) as of Q3 2023
As of 30 Sep 2023 Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) had 123 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 64,968,404 shares of stock of the company.
Largest 10 holders included FMR LLC, RA CAPITAL MANAGEMENT, L.P., NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, Vivo Capital, LLC, PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, Deep Track Capital, LP, Frazier Life Sciences Management, L.P., and FEDERATED HERMES, INC..
This table shows 123 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.